CF vs EBS
CF Industries Holdings Inc (CF) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CF currently screens at market cap $14.98B and trailing P/E 12.2. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CF and EBS stock pages for the full models.
Not investment advice.